Xabarem 10 mg film-coated tablets Malta - English - Medicines Authority

xabarem 10 mg film-coated tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - film-coated tablet - rivaroxaban 10 mg - antithrombotic agents

Xabarem 2.5 mg film-coated tablets Malta - English - Medicines Authority

xabarem 2.5 mg film-coated tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - film-coated tablet - rivaroxaban 2.5 mg - antithrombotic agents

Xabarem 15 mg film-coated tablets Malta - English - Medicines Authority

xabarem 15 mg film-coated tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - film-coated tablet - rivaroxaban 15 mg - antithrombotic agents

Xabarem 20 mg film-coated tablets Malta - English - Medicines Authority

xabarem 20 mg film-coated tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - film-coated tablet - rivaroxaban 20 mg - antithrombotic agents

CLOPIDOGREL APOTEX clopidogrel (as besilate) 75 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

clopidogrel apotex clopidogrel (as besilate) 75 mg film-coated tablet blister pack

southern cross pharma pty ltd - clopidogrel besilate, quantity: 111.86 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: mannitol; microcrystalline cellulose; colloidal anhydrous silica; stearic acid; hypromellose; titanium dioxide; iron oxide red - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.,acute coronary syndrome,clopidogrel is indicated in combination with aspirin for patients with,-unstable angina or non-st-elevation myocardial infarction in order to prevent early and long-termatherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). clopidogrel is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or pci, with or without stent).,- st-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. in thispopulation, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.